Floatz logo

Biottt001

Locally Advanced Breast Cancer (LABC)

Beijing Bio-Targeting Therapeutics Technology Co., Ltdgene_therapyPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

890 Active assets in the Locally Advanced Breast Cancer (LABC) cohort.

Asset / SponsorPhaseRating
Lapatinib
University of New Mexico
Phase 3BBB
Darolutamide
Vandana Abramson
Phase 2BBB
Trastuzumab Duocarmazine
Byondis B.V.
Phase 3BB
ERIBULIN MONOMETHANESULFONATE
Henan Cancer Hospital
Phase 4BB
Palbociclib
Hoffmann-La Roche
Phase 4BB

View all 50 →

Same molecule, other indications

Biottt001 is also rated in:

neoplastic meningitisDormant
CCC
Indicative ·
48 / 100
View asset →
Colorectal Cancer MetastaticDormant
C
Indicative ·
37 / 100
View asset →
neoplasmDormant
C
Indicative ·
36 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →